Patients 80 and older who are treated with single-agent immunotherapies for some cancers benefit from these innovative treatments and have somewhat comparable outcomes to younger people who received the same type of treatments for similar cancers, according to a landmark study published November...

OU Health designated as NORD Rare Disease Center of Excellence, joining innovative network of 31 medical centers dedicated to expanding access and advancing care and research for rare diseases.

OU College of Medicine researcher Jody Summers, Ph.D., recently discovered one of the body’s regulators of inflammation, a protein called Interleukin-6 (IL-6), plays a role in the development of myopia.

Desiree Azizoddin, PsyD, a behavioral scientist and pain psychologist joins TSET Health Promotion Research Center (HPRC) at the University of Oklahoma Health Sciences Center.



Grand Rounds